Bibliographic citations
Hilares, M., Quispe, S. (2024). Reacciones adversas inmediatas a las vacunas contra covid- 19 en adultos en el distrito de Cerro Colorado-Arequipa, diciembre 2022 - abril 2023 [Universidad María Auxiliadora]. https://hdl.handle.net/20.500.12970/2406
Hilares, M., Quispe, S. Reacciones adversas inmediatas a las vacunas contra covid- 19 en adultos en el distrito de Cerro Colorado-Arequipa, diciembre 2022 - abril 2023 []. PE: Universidad María Auxiliadora; 2024. https://hdl.handle.net/20.500.12970/2406
@misc{renati/1112938,
title = "Reacciones adversas inmediatas a las vacunas contra covid- 19 en adultos en el distrito de Cerro Colorado-Arequipa, diciembre 2022 - abril 2023",
author = "Quispe Yucra, Sandra Raquel",
publisher = "Universidad María Auxiliadora",
year = "2024"
}
The objective of this study was to determine the frequency of immediate adverse reactions (ADRs) as an effect of the application of vaccines against Severe Acute Respiratory Syndrome Coronavirus 2 (Covid-19) in the inhabitants of Cerro Colorado Arequipa between December 2022 and April 2023. The research had a quantitative approach, with a methodological approach of a non-experimental correlational study, the data collection technique used was the survey applied to 382 inhabitants between 30 and 60 years of age who went to FarmaSalud and Farmazul pharmaceutical establishments. The survey was validated by three teachers from the María Auxiliadora University, the instrument was a questionnaire made up of a total of 36 questions, this information was collected and analyzed in an Excel spreadsheet and presented in frequency tables. It was found that the most frequent adverse reactions were: fever and headache with 62%, and pain at the site of application with 76%. Regarding the vaccine that presented the greatest adverse reaction was Pfizer with 46.1 %. In conclusion, the most frequent adverse reaction in persons between 30 and 60 years of age was pain with 41.1 % and the vaccine that presented more adverse reactions was Pfizer with 46.1 %.
This item is licensed under a Creative Commons License